The Multi-pathway Mechanism and Co-delivery System of Oleanolic Acid Derivatives in Reversing Chemotherapy Resistance...

Area of Science:

• Oncology
• Natural Product Chemistry
• Medicinal Chemistry

Background:

• Breast cancer poses a significant global health challenge, with chemotherapy often leading to side effects and drug resistance.
• Natural compounds offer a promising avenue for developing alternative breast cancer therapies that circumvent resistance issues.
• Oleanolic acid (OA), a pentacyclic triterpenoid, exhibits known anticancer properties and a favorable safety profile, making it a candidate for drug development.

Purpose of the Study:

• To comprehensively review the anticancer mechanisms of oleanolic acid (OA) and its derivatives against breast cancer.
• To consolidate current knowledge on OA derivatives with proven or potential clinical applications in breast cancer treatment.
• To highlight OA as a scaffold for synthesizing novel anti-breast cancer agents.

Main Methods:

• Literature review of preclinical and clinical studies on oleanolic acid and its derivatives in breast cancer.
• Analysis of reported biological activities and mechanisms of action.
• Synthesis and evaluation of structure-activity relationships for OA derivatives.

Main Results:

• Oleanolic acid (OA) demonstrates significant biological activity against breast cancer cells with minimal toxicity to normal cells.
• Various OA derivatives have been synthesized and exhibit potent anti-breast cancer effects.
• Some OA derivatives are in clinical trials or are candidates for further development, indicating therapeutic potential.

Conclusions:

• Oleanolic acid (OA) and its derivatives represent a valuable class of natural compounds for breast cancer therapy.
• The anticancer mechanisms of OA derivatives warrant further investigation for optimized drug design.
• OA serves as a promising molecular framework for developing novel, effective, and safer breast cancer drugs.